*ST Weiming Co., Ltd.
*ST未名
002581
Shenzhen Stock Exchange
Key Financials
As of 2026-05-23T00:00:00.000+00:00Announcements
Announcement on Receiving Dividends from Associated Companies
Announcement on Participating in the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Region
Announcement on abnormal fluctuations in stock trading
Announcement on Abnormal Stock Trading Volatility
Announcement on the Application for Comprehensive Credit Limit from the Bank
2025 Q3 Report (Corrected)
Explanation by the Board on the Correction of Prior Accounting Errors and Retrospective Adjustments
Announcement on the Correction of Prior Accounting Errors and Retrospective Adjustments
Reasonableness Explanation by the Audit Committee of the Board on the Correction of Prior Accounting Errors and Retrospective Adjustments
2025 Annual Independent Director Work Report (Cai Yanhong)
2025 Annual Independent Director Work Report (Liu Yang) - Resigned
2025 Annual Independent Director Work Report (Yang Jun)
2025 Annual Independent Director Work Report (Xia Yang)
2025 Annual Independent Director Work Report (Zhang Rongfu)
2025 Annual Internal Control Audit Report of Shandong Weiming Biomedical Co., Ltd.
2025 Annual Internal Control Rules Implementation Self-Check Form
2025 Annual Internal Control Self-Evaluation Report
Announcement on the Confirmation of 2025 Compensation for Directors and Senior Management and the 2026 Compensation Plan
Compensation Management System for Directors and Senior Management
Announcement on Changes in Accounting Policies
Announcement on the Provision for Asset Impairment for 2025
Reasonableness Explanation by the Audit Committee of the Board on the Provision for Asset Impairment for 2025
Announcement on Providing Financial Assistance to the Controlling Subsidiary
2025 Annual Board Work Report
Notice of the 2025 Annual Shareholders' Meeting
Resolution Announcement of the 12th Meeting of the 6th Board of Directors
Announcement on the Company's Profit Distribution Plan for 2025
Q1 2026 Report
Special Explanation on the Non-Standard Audit Opinion on the 2025 Financial Statements of Shandong Weiming Biomedical Co., Ltd.
Notes & Comments
Sign in to leave a comment or private note.
Loading…